Topical corticosteroids in psoriasis: strategies for improving safety |
| |
| Authors: | EJ Horn S Domm HI Katz M Lebwohl U Mrowietz K Kragballe for the International Psoriasis Council |
| |
| Institution: | 1. International Psoriasis Council, Dallas, Texas, USA;2. Psoriasis‐Center at the Department of Dermatology, University Medical Centre Schleswig‐Holstein, Campus, Kiel, Germany;3. Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA;4. Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA;5. Department of Dermatology, ?rhus University Hospital, ?rhus, Denmark |
| |
| Abstract: | Corticosteroids are a mainstay of topical therapy for psoriasis. While efficacious and relatively safe when used carefully, the potential for side effects, notably skin atrophy and adrenal suppression, have been associated with excesses in potency, prolonged or widespread use. The International Psoriasis Council Working Group on Topical Therapy has reviewed the efficacy and safety of topical corticosteroids and recommends strategies for safe, long‐term use of these agents. |
| |
| Keywords: | corticosteroids psoriasis safety topical therapy |
|
|
